Therefore, we are reporting for the first time the NMR data and BCRP-inhibitory activity of this compound, and characterizing its ability to resensitize SN-38 resistant colon cancer cells toward SN-38 without significantly affecting cell viability by itself. Here, ABCG2 is linked to colonic neoplasm.